Mareana expands its AI-based product offering, revolutionizing data management for pharma and biotech manufacturing with Connect CMC™
Princeton, NJ, February 22, 2024—Mareana, a leader in innovative data management solutions, announces the launch of Connect CMC™, a ground-breaking AI-powered tool specifically designed to transform how small pharmaceutical and biotechnology companies manage and analyze data from drug manufacturing processes. This latest offering promises to revolutionize data handling in the pharmaceutical and biotech industries, especially for companies relying on paper batch records.
As biotech, pharma, and cell therapy manufacturers seek to modernize even while complying with audit requirements and optimizing their processes, Connect CMC™ is an ideal solution to accelerate the digital transformation in this industry. It addresses critical industry challenges by automating the extraction and contextualization of data from paper batch records and other third-party sources. Built with GxP compliance in mind, this tool not only ensures the accuracy and reliability of data but also enhances operational efficiency and decision-making processes.
“Our mission with Connect CMC™ is to empower pharmaceutical companies, particularly those in the pre-commercial stage, to focus on their core objective: developing life-saving drugs,” said Prashant Kumar, CEO of Mareana. “Connect CMC™ is more than just a data management tool; it’s a solution that allows scientists and researchers to dedicate their time and expertise to innovation rather than getting bogged down by the manual data extraction and analysis.”
Key features of Connect CMC™ include:
- AI-powered Automation: Streamlines data extraction, ensuring efficiency and accuracy.
- Scalability and Cost-Effectiveness: Adapts to growing data and process needs for both small-scale and large, multi-site operations.
- Intuitive User Interface: Minimizes training time and maximizes productivity.
- Consolidated Knowledge Hub: Facilitates collaboration across teams and with external partners.
- Comprehensive Traceability and Audit Readiness: Offers end-to-end data traceability and built-in audit capabilities.
“Connect CMC™ is designed to streamline drug development, providing instant support for investigation and analysis at a fraction of your current cost,” states Vishal Prasad, Co-Founder and CPO at Mareana Inc.
Targeted at companies using paper batch records and those collaborating with Contract Development and Manufacturing Organizations (CDMOs), Connect CMC™ not only speeds up the data analysis process but also assists in timely batch record release and comprehensive audit preparations.
Connect CMC™ is now available as a Software as a Service (SaaS) offering and is hosted on Mareana’s validated cloud platform. For more information about Connect CMC™ or to request a demo, visit [Website] or contact [Contact Information].
About Mareana
Established in 2015, Mareana is a leading Manufacturing Intelligence Platform company focusing on the biotech and pharma manufacturing markets. To date, it has contributed over $1 billion in value to its clients. Acknowledged as a Cool Vendor in AI by Gartner, Mareana leads through innovation and customer-centricity in their products—Connect CMC™ and Connect CPV™.
